期刊文献+

乳腺癌BRCA1-mRNA表达及启动子区甲基化状态与临床病理特征的相关性 被引量:3

Correlation between BRCA1-mRNA expression,promoter methylation status and clinicopathological features in breast cancer
下载PDF
导出
摘要 目的探究乳腺癌易感基因1-mRNA(BRCA1-mRNA)水平及启动子区甲基化状态与乳腺癌患者临床病理特征的相关性。方法选取2016年2月至2018年2月于西安交大一附院确诊为乳腺癌的350例患者为实验组,另选取同期行体检的50例健康女性为对照组,分别检测两组受检者的BRCA1-mRNA水平、启动子区甲基化状态,分析BRCA1-mRNA水平与启动子区甲基化状态相关性。结果实验组BRCA1-mRNA水平低于对照组,启动子区甲基化阳性状态比率显著高于对照组(P <0.05);实验组患者BRCA1-mRNA水平、启动子区甲基化状态与其年龄、TNM分期无相关性,前者与肿瘤大小存在相关性(P <0.05);后者与组织学分级存在相关性(P <0.05)。结论乳腺癌患者BRCA1-mRNA水平与肿瘤大小有关,启动子区甲基化状态与其组织学分级有关,可以作为判断乳腺癌肿瘤状态的实验室指标。 Objective To investigate the correlation between breast cancer susceptibility gene BRCA1-mRNAs,promoter methylation status and clinicopathological features of breast cancer patients.Methods From February 2016 to February 2018,350 patients with breast cancer diagnosed in the first affiliated Hospital of Xian Jiaotong University were selected as the experimental group,and 50 healthy women who underwent physical exami-nation were selected as the control group. The BRCA1-mRNA levels of the two groups were measured respectively.The methylation status of promoter region was analyzed and the correlation between BRCA1-mRNA level and pro-moter methylation state was analyzed.Results The level of BRCA1-mRNA in the experimental group was lower than that in the control group,and the positive rate of methylation in the promoter region was significantly higher than that in the control group(P < 0.05),but there was no correlation between the level of BRCA1-mRNA and the methylation status of the promoter region in the experimental group. The former was correlated with tumor size(P <0.05)and the latter with histological grade(P < 0.05).Conclusion The level of BRCA1-mRNA in breast cancer patients is related to the tumor size,and the methylation status of promoter region is related to the histological grade,which can be used as a laboratory index to judge the tumor status of breast cancer.
作者 李晓锋 汪园园 刘希 LI Xiaofeng;WANG Yuanyuan;LIU XI(Department of Pathology,First Affiliated Hospital of Xi'an Jiaotong University,Xi'an 710061,China)
出处 《实用医学杂志》 CAS 北大核心 2018年第24期4089-4092,共4页 The Journal of Practical Medicine
基金 陕西省国际科技合作与交流计划(编号:2016KW-009)
关键词 乳腺癌 BRCA1-mRNA 启动子区甲基化 病理特征 易感基因 breast cancer BRCA1-mRNA promoter methylation pathological features susceptibility gene
  • 相关文献

参考文献3

二级参考文献30

  • 1SCULLY R,LIVINGSTON DM.In search of the tumour - suppressor functions of BRCA1 and BRCA2[J].Nature,2000,408(6811):429-432.
  • 2JOC JG,CSANAdm,TOTH K,et al.Risk assessment in familial HYPERLINK "http ://www.ncbi.nlm.nih.gov/pubmed/21498166"breastHYPERLINK "http ://www.ncbi.nlm.nih.gov/ pubmed/21498166" cancerHYPERLINK "http ;//www.ncbi.nlm.nih.gov/pubmed/21498166"[J]HYPERLINK "http:// www.ncbi.nlm.nih.gov/pubmed/21498166".Orv Hetil,2011,152(19):758-762.
  • 3PAL T,BONNER D.A high frequency of BRCA mutations in young black women with breast cancer residing in Florida [J].Cancer,2015,121(23):4173-4180.
  • 4LARAQUI A,UHRHAMMER N,RHAFFOULI HE,et al.BRCA genetic screening in Middle Eastern and North African : mutational spectrum and founder BRCAl mutation (c.798_799delTT) in North African[J].Dis Markers,2015,2015:194293.
  • 5KANG E,SEONG MW,PARK SK,et al.The prevalence and spectrum of BRCA1 and BRCA2 mutations in Korean population : recent update of the Korean Hereditary Breast Cancer (KOHBRA) study[J].Breast Cancer Res Treat,2015,151(1):157-168.
  • 6GANGI A,CASS I,PAIK D,et al.Breast cancer following ovarian cancer in BRCA mutation carriers [J],JAMA Surg,2014,149(12):1306-1313.
  • 7LI YT,NI D,YANG L,et al.The prevalence of BRCA1/2 mutations of triple -negative breast cancer patients in Xinjiang multiple ethnic region of China [J].Eur J Med Res,2014,19:35.
  • 8KWONG A,CHU AT,WU CT,et al.Attitudes and compliance of clinical management after genetic testing for hereditary breast and ovarian cancer among high -risk Southern Chinese females with breast cancer history [J].Fam Cancer,2014,13(3):423-430.
  • 9DE BRUIN MA,KWONG A,GOLDSTEIN BA,et al.Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations [J].Fam Cancer,2012,11(3):429-439.
  • 10KWONG A,NG EK,WONG CL,et al.Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis [J].PLoS One,2012,7(9): e43994.

共引文献21

同被引文献20

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部